OBIO
Orchestra BioMed Holdings Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$4.20
-0.18 ▼ -4.11%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$4.20
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -1.29 | Insider Own | 25.23% | Shs Outstand | 0.06B | Perf Week | -2.78% |
| Market Cap | 0.25B | Forward P/E | - | EPS next Y | 12.44% | Insider Trans | 0.04% | Shs Float | 0.04B | Perf Month | 3.45% |
| Enterprise Value | 0.18B | PEG | - | EPS next Q | -0.43 | Inst Own | 38.85% | Short Float | 1.89% | Perf Quarter | -10.06% |
| Income | -0.05B | P/S | 7.34 | EPS this Y | -53.93% | Inst Trans | -1.64% | Short Ratio | 3.86 | Perf Half Y | 60.31% |
| Sales | 0.03B | P/B | 4.47 | EPS next 5Y | 5.17% | ROA | -55.18% | Short Interest | 0.80M | Perf YTD | 1.2% |
| Book/sh | 0.94 | P/C | 2.31 | EPS past 3/5Y | 20.91% -164.92% | ROE | -109.41% | 52W High | -22.57% ($5.42) | Perf Year | 9.38% |
| Cash/sh | 1.82 | P/FCF | - | Sales past 3/5Y | 111.62% - | ROIC | -55.7% | 52W Low | 90.91% ($2.20) | Perf 3Y | -73.86% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 22.24% | Gross Margin | 98.58% | Volatility(W/M) | 8.2% 6.88% | Perf 5Y | -63.48% |
| Dividend TTM | - | EV/Sales | 5.42 | Sales Y/Y TTM | 1169.22% | Oper. Margin | -154.73% | ATR (14) | 0.31 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 6.43 | EPS Q/Q | 124.71% | Profit Margin | -158.16% | RSI (14) | 47.55 | Recom | 1.43 |
| Dividend Gr. 3/5Y | - | Current Ratio | 6.45 | Sales Q/Q | 12120.16% | SMA20 | -1.64% ($4.27) | Beta | 0.59 | Target Price | $13 |
| Payout | - | Debt/Eq | 0.51 | Earnings | 3000000 | SMA50 | 0.09% ($4.2) | Rel Volume | 1.35 | Prev Close | $4.38 |
| Employees | 86 | LT Debt/Eq | 0.5 | EPS/Sales Surpr. | 131.29% 3220.84% | SMA200 | 18.02% ($3.56) | Avg Volume(3M) | 0.21M | Price | $4.2 |
| IPO | 2020/8/4 | Option/Short | Yes/Yes | Trades | 3562 | Volume | 278,588 | Change | -4.11% |
뉴스 로딩 중...